|
|
Key Takeaways from the 2022 IMWG Summit
IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie elaborates on key takeaways from the recently concluded 13th Annual International Myeloma Working Group (IMWG) Summit, which was held in Vienna, Austria from June 7-9, 2022. In his blog, Dr. Durie brings a 2022-2026 perspective and highlights key points from presentations made by myeloma experts on a variety of topics: a summary of the results and findings from the iStopMM screening of more than 80,000 individuals; an evaluation of simple precise testing as a means to identify high-risk smoldering multiple myeloma (HR SMM); results of various treatments for HR SMM; an assessment of the current status of minimal residual disease (MRD) testing; and more! To learn more about these key takeaways in-depth, read Dr. Durie’s blog.
|
|
|
|
|
|
|
Watch the Replay: IMWG Conference Series 2022 – Making Sense of Treatment
Today, June 16th, at the IMWG Conference Series, “Making Sense of Treatment,” leading myeloma experts discussed the latest drug therapy news from the June 2022 American Society of Clinical Oncology (ASCO) Annual Conference, IMF IMWG Summit, and the European Hematology Association (EHA) Annual Conference. Moderated by IMF Chairman of the Board Dr. Brian G.M. Durie, panelists included Drs. Vincent Rajkumar (Mayo Clinic—Rochester, MN) and María V. Mateos (University of Salamanca—Salamanca, Spain). In case you missed it, you can still watch the replay.
|
|
|
|
|
|
|
This Week: IMF Virtual Regional Community Workshop (RCW) - New England
The IMF Regional Community Workshop – New England will be held this Saturday, June 18 at 7:00 a.m. PT/ 8:00 a.m. MDT/ 9:00 a.m. CT/ 10:00 a.m. ET. IMF Senior Director of Regional Community Workshops Kelly Cox will kick off the workshop. Guest speakers include Rafat Abonour, MD, (Indiana University—Indianapolis, IN), Raymond Comenzo, MD (Tufts Medical Center—Boston, MA), and IMF Nurse Leadership Board (NLB) Member Kimberly Noonan, DNP, ANP-BC, AOCN (Dana-Farber Cancer Institute—Boston, MA). The workshop will include an introduction to myeloma, upfront treatments at diagnosis, maintenance therapy, relapse information, and an update on clinical trials. IMF NLB Member Kimberly Noonan will talk about managing side effects and symptoms of myeloma and its treatments. After each presentation with the experts, attendees will have ample time to ask questions.
|
|
|
|
|
|
|
June 19 is Father’s Day! Shop AmazonSmile and Give to the IMF
When you shop at smile.amazon.com and designate the International Myeloma Foundation (IMF) as your preferred charity, Amazon donates 0.5% of all purchases you make to the IMF, at no added cost to you. Make this Father’s Day special by shopping at AmazonSmile while giving to the IMF at the same time!
|
|
|
|
|
|
|
Las Voces De Mieloma Support Group (Spanish-Virtual Meeting) on June 21
Las Voces de Mieloma Support Group will hold its Spanish virtual meeting on June 21, Tuesday from 10:00 a.m. – 11:00 a.m. (Pacific Standard Time). Guest speaker will be Prof. Jesús San Miguel who is currently Director of Clinical and Translational Medicine at the University of Navarra and Medical Director of the Clínica Universidad de Navarra. Previously, he was Professor of Medicine at the University of Salamanca, Head of the Hematology Service of the University Hospital (22 years) and President of the International Myeloma Society. He has been Associate Editor of Blood and Hematologica and member of the advisory committees of the European Hematology Association, the Leukemia Research Foundation, the International Myeloma Foundation, and the Multiple Myeloma Research Foundation. He has received numerous awards, including the recent Gregorio Marañón National Research Award for the area of Medicine 2021, previously the "KNAW Bob Pinedo Cancer Care Award 2020" awarded by the Royal Netherlands Academy of Arts and Sciences and the Bob Pinedo Cancer Care Foundation, the International Waldenström Award, Kyle Life Achievement Award, Jose Carreras Award, Ham-Wasserman Lecture Award, Celgene Life Achievement Career Award, EBMT Lecture Award, Michaeli Award and the King Jaime I Award for Medical Research. His scientific production translates into more than 880 international publications. To join the meeting, please register at: https://lasvoces.support.myeloma.org/. Once registered, you will receive an email with meeting log in information.
|
|
|
|
|
|
|
Living Well with Myeloma Webinar on June 23
The Living Well with Myeloma Webinar, on Thursday, June 23, at 7 p.m. ET, will focus on “A Promising Future for Treating Multiple Myeloma with Bispecific Antibodies.” IMF Vice President of Support Groups Robin Tuohy will moderate presentations with the following speakers: Donna Catamero, ANP-BC, OCN, CCRC (The Mount Sinai Health Center—New York, NY, IMF Nurse Leadership Board), and Tom Martin, MD (University of California San Francisco—San Francisco, CA). To ensure patients and care partners better understand the promising future in bispecific therapies, please tune in to this Live Webinar to hear from Tom Martin, MD and Donna Catamero, ANP-BC, OCN, CCRC, as they cover key questions, concerns, and highlights.
|
|
|
|
|
|
|
M-Power: Changing the Course of Myeloma in the African American Community
The IMF M-Power Initiative is focused on changing the course of myeloma in the African American community. Myeloma is two times as common in people of African descent as it is in all other races and ethnicities. Empower yourself by joining our 2nd virtual M-Power Charlotte webinar on June 25, 10 a.m.–12:30 p.m. ET. Event panelists include Dr. Peter Voorhees (Levine Cancer Institute – Charlotte); Tiffany W. Crank, MPH (Levine Cancer Institute – Charlotte); IMF Nurse Leadership Board member Amy E. Pierre, RN, MSN, ANP-BC; local myeloma patient and advocate, Pastor Robert Pugh; IMF Patient, President & CEO Yelak Biru; and IMF Chief Medical Officer Dr. Joseph Mikhael. Panelists will be participating in real time and answering your questions.
|
|
|
|
|
|
|
Download Understanding Dexamethasone in the Treatment of Myeloma – 2022 Edition
This booklet discusses dexamethasone, a synthetic steroid that is one of the most frequently used medications in the treatment of myeloma. It can be given as either an oral tablet or as an injection, alone or in combination with other agents. Dexamethasone’s anti-inflammatory actions can stop the swelling around tumors and the resulting pain and other symptoms caused by tumors pressing on nerve endings. Get your FREE copy of the IMF’s Understanding Dexamethasone in the Treatment of Myeloma in printed form or as a downloadable PDF with hyperlinks to informative resources.
|
|
|
|
|
|
Instagram @IMFmyeloma